Search Weight Loss Topics:


Page 86«..1020..85868788..100..»


Nov 24

Bioethics in Practice: Battle of the Sexes Talent or Testosterone? – The Commentator

Gender, as both a means of identification and a sociological construct, is constantly evolving. The traditional two gender system has been supplanted by an expanding lexicon that includes nonconforming terms such as genderqueer, gender fluid and non-binary. In order to mitigate misgendering, it is now common in diverse workplaces to include in ones email signature preferred gender pronouns, such as he/him/his, she/her/hers or the gender-neutral, they/them/theirs.

Whereas differential treatment by gender is illegal in many domains, such as medical care, employment and education, sports remains one of the few areas in which it is legal, and in fact necessary, to differentiate between males and females, consequently creating an international bioethics controversy.

Most recently, the controversy surrounds South African Olympic athlete Caster Semenya, who holds two 800-meter Olympic titles and three world titles. Semenya was born and raised as a female, as she has external female sexual characteristics and identifies as cisgender. Yet, after being forced to undergo sex-determination testing following her 2009 Berlin victory, Semenya was diagnosed with 46, XY disorder of sex development (DSD), a congenital condition in which her chromosomal makeup is XY, the normal male chromosomal pattern, yet her external anatomical development is typical of a female. Individuals with DSDs are often referred to as intersex, and conditions such as 46, XY DSD, in which a persons reproductive anatomy or appearance is not consistent with their 23rd chromosomal pair, are termed sex reversal.

In April 2018, the International Association of Athletics Federations (IAAF) issued new eligibility regulations for female athletes with DSDs, requiring them to reduce their blood testosterone levels to below 5 nMol/L which the IAAF considers the upper limit of natural female levels in order to be allowed to compete in certain female events. They were advised to do so via hormone therapy. Although the International Court of Arbitration for Sport (CAS) upheld the IAAF regulations in an Executive Summary they released this past May, Semenya refuses to take any hormone-suppressing drugs and continues to contest the decision in court.

According to CASs report, both parties agree on the necessity of gender division in sports, as there is a substantial difference in elite sports performance between males and females. This assumption is the basis of separate mens and womens teams in every athletic level, from Little League to the Olympics, and it is at the heart of the historically-famous Battle of the Sexes tennis match between Billie Jean King and Bobby Riggs.

However, the ethical issue surrounding CASs controversial policy hinges on the acceptability of using testosterone levels as the determining metric for gender categorization in DSD athletes. While varying levels of testosterone contribute to the differential performance of males and females in sports such that testosterone contributes to the power and size of skeletal muscle and the number of red blood cells the degree to which elevated testosterone levels confer a significant competitive edge is a matter of scientific debate.

Proponents of the CAS ruling err on the side of caution: although the decision may be discriminatory to DSD athletes, as it bans them from competing in events based on a congenital condition that is beyond their control, it ensures athletic fairness and preserves the original purpose of gender divisions in sports. Since there must be a concrete basis on which to distinguish between male and female athletes, testosterone levels seem like the best option since it can be scientifically linked to athletically-superior traits. Thus, if a 46, XY DSD athlete can lower her blood testosterone level to 5 nMol/L, she would be allowed to compete, as her competitive advantage would be diminished.

However, the opposing opinion argues that testosterone cannot be used as a metric, since biologically, it is not the sole determinant of athletic prowess. High testosterone levels is just one single factor that contributes to athleticism, among others such as height, natural agility and coordination, body structure, and mental toughness. What distinguishes Usains Bolts height and Michael Phelpss reduced lactic acid production from Caster Semenyas advantageous physical traits? In fact, Eero Mntyranta, a Finnish Olympian skier who won seven medals, had a condition called polycythemia, which causes abnormally elevated blood hemoglobin and red blood cell concentrations due to a mutation in the erythropoietin-receptor gene. Although his increased oxygen-carrying capacity undoubtedly conferred a competitive advantage, Mntyranta competed without opposition. How is his case different than Semenyas?

Furthermore, to take CASs decision to its natural conclusion, what would the policy be against XX females who naturally produce levels of testosterone that exceed 5nMol/L, such as with women who have the inherited disorder congenital adrenal hyperplasia? Although such a woman would have elevated testosterone levels akin to Semenyas, the former would be allowed to compete simply because her inherent chromosomal makeup is typical of a female, regardless of the substantial difference in athletic performance that the IAAF and CAS claim is caused by testosterone.

As a female collegiate athlete, I appreciate the merits and shortcomings of both sides of the discussion. Although maintaining fairness in sports is a significant value, Semenyas case begs us to consider the ethical implications of basing an international policy on controversial scientific evidence and such a decisions ramifications for future gender-related policies.

Photo Caption: Caster SemenyaPhoto Credit: Wikimedia Commons

See more here:
Bioethics in Practice: Battle of the Sexes Talent or Testosterone? - The Commentator


Nov 24

Jim Ratcliffe says hell pull Ineos out of cycling if there is evidence of cheating – Cycling Weekly

Jim Ratcliffe, the owner of Ineos, has said he would pull his sponsorship of the British squad if there was any evidence that his team were not a clean cycling operation.

The re-iteration of his confidence in Brailsford and the Ineos team comes as former Team Sky and British Cycling doctor Richard Freeman is involved in a hearing where he stands accused by the General Medical Council of ordering testosterone in 2011 to help a rider dope. Freeman denies the charges.

>>>Tour de Yorkshire route 2020: host locations revealed

Dave will have to dealwith that side, Ratcliffe told the Times. I am not interested in the history, just our watch and going forward. If there are any issues for Dave he will have to deal with those. There is nothing happening in our team.

After Sky announced they were ending their sponsorship of the British team, Ratcliffe stepped in to plug the 40 million funding gap with his petrochemical giant, continuing to provide the biggest budget of any WorldTour outfit. The British businessman says that before he agreed to put his money in rigorous checks were made to ensure he was investing in a legitimate, clean operation.

We checked all the procedures, everything, doctors records, Ratcliffe said. You buy a cycling team, there wasnt much legal work to do but we spent a lot of time on due diligence on the team.

We had external lawyers do those checks, looking at the procedures, testing. We took it seriously. The regulations when we bought, and the procedures in Team Sky, were the most sophisticated and rigorous in the cycling world.

Freemans tribunal is also investigating whether he failed to maintain adequate records and that he failed to ensure records on a laptop, stolen in August 2014, could be retrieved.

One of the latest developments in the case revealed that Freeman downloaded an academic article detailing testosterone boosting drugs a month before ordering Testogel.

See the original post here:
Jim Ratcliffe says hell pull Ineos out of cycling if there is evidence of cheating - Cycling Weekly


Nov 24

Why Customized Treatment for Low Testosterone or ED Is One of the Best Things You Can Do for Your Health as a Man – The Good Men Project

Given societys preoccupation with fulfilling sex, its easy for a man to get sucked into sleazy advertisements that promise herculean erections or nirvana-esque sexual pleasure. Countless men associate sexual potency with actual potency due to a combination of anatomical and social realities. Consequently, it can be a major source of shame to fail to perform up to par.

Dont think of how your sexual performance will decline. Think of how it can improve.

Yes, its true that more than half of all men over 40 have problems with erectile dysfunction. And starting at age 30, men lose on average 1 to 3 percent of their testosterone production per year. Add to that the additional health problems that often arise as men age, and its no wonder that there is increased anxiety over sexual performance.

But there is no shame in recognizing when a little help is needed to keep things on the up-and-up. Its never too early to start taking your sexual health and overall wellbeing seriouslyand not just for your own sake but for the sake of your partner(s).

Visit a Universal Mens Clinic, and you wont just get a standard drug prescription and be sent on your way. Universal Mens Clinics combine the skills of physicians, nurse practitioners, and naturopaths who understand the complexity of the male body and are devoted to helping men feel their bestboth inside and outside the bedroom.Check out one of the 11 locations in eight states to find the clinic that best suits your needs.

Solving a problem like Low Testosterone will help you increase not only your sex drive, but also your overall energy level so that youre at your best during the day and at night. Other benefits include increased muscle mass, decreased belly fat, and an improved outlook on life. Treatments for erectile dysfunction and premature ejaculation will give you the confidence you need in the bedroomand that confidence can stay with you all day long.

Universal Mens Clinics have a patient satisfaction rate of 90 percent.Customized treatments lead to customer satisfaction.

Dont kiss your sex life goodbye as you age.

Universal Mens Clinics offer a range of treatments to meet individual needs. The clinic offers oral medications, soft tabs, creams, and injectionsand its medical providers are open to discussing the best treatment program for you. There is no one-size-fits-all solution when it comes to sexual health, and, unlike some competitors, wont promise you a magic pill that offers spectacular results at a premium. They will only offer the best care based on the best science.

Make your later years your best years: Visit a Universal Mens Clinic today!

UniversalMensClinic.com

Sponsored by Universal Mens Clinic

Photo: Shutterstock

Read this article:
Why Customized Treatment for Low Testosterone or ED Is One of the Best Things You Can Do for Your Health as a Man - The Good Men Project


Nov 24

Freeman’s lawyer to attempt to have testosterone charges thrown out – Cyclingnews.com

Former British Cycling and Team Sky doctor Richard Freeman may attempt to have the testosterone charges thrown out of the medical tribunal that is currently assessing his fitness to practise.

On Thursday, Freeman's lawyer, Mary O'Rourke QC, indicated she is poised to issue a 'half-time submission' based on the argument the General Medical Council (GMC), which has brought the case against Freeman, cannot substantiate its allegations.

"The GMC has no evidence to support its case," O'Rourke stated, according to the BBC. If successful, the submission, which would wouldn't be made before late next week, could see the remaining charges dropped mid-way through the process.

The GMC brought no fewer than 22 allegations against Freeman, but he is only contesting four of them, all relating to the delivery of testosterone gel to British Cycling and Team Sky headquarters in June 2011.

Having previously denied ordering the banned substance, and falsely claiming it had been returned to the supplier, Freeman has admitted to the tribunal he did order it but claims it was to treat erectile dysfunction in Shane Sutton. Sutton vehemently denied the accusation, along with any knowledge of the delivery, before storming out of the tribunal last week.

Of the four contested allegations, the central one is number 12: "You placed the Order and obtained the Testogel a) when you knew it was not clinically indicated for the non-athlete member of staff, b) knowing or believing it was to be administered to an athlete to improve their athletic performance."

Part b) was amended before the tribunal formally opened, having previously read that Freeman ordered the Testogel "to administer to an athlete...".

On Thursday, O'Rourke, who had resisted the GMC's amendment request, insisted the GMC had no evidence to substantiate its allegations "even as amended".

A half-time submission would only be issued once it is decided how Sutton's testimony should be treated, which is currently being debated by the tribunal. Given the manner of his departure, and the fact he didn't return for the second scheduled day of evidence-giving, there are question marks over how much weight will be given to his testimony, if it should be considered at all.

While O'Rourke wants Sutton's evidence scrapped, the GMC's lawyer, Simon Jackson QC, blamed O'Rourke for inciting Sutton's angry departure, after she accused him of being a "serial liar" and a "doper with a doping history".

"The nature and tone of the cross-examination was deliberately focused not on the Testogel, but to make allegations of doping," Jackson said, according to the BBC.

O'Rourke described that as "nonsense" and blamed the GMC for not issuing a witness summons to ensure he returned. "The GMC has created this problem," she said, according to the Mail. "He has been led to believe his attendance was voluntary."

The debate over Sutton's evidence and a possible half-time submission followed another eventful day on Wednesday in which it was revealed Freeman had downloaded articles to his laptop on the testosterone-boosting drugs and the relationship between testosterone levels and endurance exercise.

The trial continues.

See the article here:
Freeman's lawyer to attempt to have testosterone charges thrown out - Cyclingnews.com


Nov 24

Symptoms of Low Testosterone in Men – FortuneHerald

Testosterone levels decline naturally with age, typicallyfrom the age of 30 years old. However, testosterone levels are declining, whatis normal now, was abnormal a few years ago. Thresholds for treatment are loweringas the normal range is skewed to represent what is normal now, it reflects asick society.

Its important to recognise the symptoms of low testosterone, its important to address possible reversible causes. The aim of life should be to lead a productive life, full of adventure, full of calculated misadventure. It should be rich; it should be colourful. It is a journey and you are in the driving seat. It might sound flouncy, its supposed to, what Im trying to highlight, it the importance of hormonal health in mental well-being. Its not the be all or end all, but low testosterone is associated with low mood, anxiety and depersonalisation. Depersonalisation is a state where you are present but not involved, merely a passenger, without a true or appropriate perspective. An element of mental illness is always a presenting symptom.

Mental illness is a spectrum, much like mental well-being,it can be mild, moderate or severe. Lack of drive and determination iscommonplace, men often describe lack of enjoyment (anhedonia) in things theirformer selves would enjoy. It can bework related, but often its an unsettling disconnect with family and friends.They are not themselves.

Cognitive decline is another alarming symptom. Men often usethe phrase brain fog to describe the lack of clarity of thought. Fogginess ora blanket descending over their thoughts accurately puts into words what isdifficult to describe. It can be as trivial as forgetting where you put yourkeys, but it can be troublesome short-term memory loss and an alarming drop inmental aptitude and sharpness.

Fatigue is vague but debilitating. Men have often soughtanswers and solutions to no avail. A good nights sleep is a rarity despitebest efforts and good sleep hygiene. Perhaps worsened by night sweats from lowoestrogen, but a perceived good nights rest is not met with a refreshedfeeling in the morning. A healthy diet does not reward you with an abundance ofenergy, irrespective of whether food is fuel.

Libido or sex-drive is often flagging. Alongside this comes erectile dysfunction,but the two can be independent. Testosterone is the male sex-hormone, but itsrole in overall health has often been trivialised as a result of thisassociation.

Physical symptoms such as weight gain, loss of muscle mass,decreased bone mineral density etc are less frequent presenting symptoms. Theyshould not be dismissed, one of my patients has osteoporosis as a result of lowtestosterone and is awaiting spinal surgery.

Know your body, know the symptoms of low testosterone.Address the fundamentals of health, lifestyle, nutrition and exercise. Stoplooking for quick fixes, build from the foundation upwards to make changesustainable.

Dr Robert Stevens MBChB MRCGP Dip.FIPT

Original post:
Symptoms of Low Testosterone in Men - FortuneHerald


Nov 24

Transgender dad used IVF to conceive his son: ‘We were really lucky’ – Yahoo Lifestyle

Atransgenderfather who used his own egg to conceive his 4-year-old son is opening up about his long path to parenthood.

Seth and Leah Marlow, of Roanoke, Va., welcomed little Arlo four years ago using reciprocalin vitro fertilization with Seths egg combined with donor sperm to make an embryo that was then carried to term by Leah.

Although Seth transitioned in 2003, underwent a double mastectomy in 2005, and takes weekly testosterone shots, he kept his ovaries, in part, to one day start a family.

However, in order to donate an egg, Seth had to re-start menstruation (which had ceased), stop taking testosterone, and use medication to stimulate the ovaries for a period of time that was awful and uncomfortable. I didnt feel like myself like I was walking in the wrong pair of shoes, the 41-year-old technology trainertells Yahoo Lifestyle. Still, you have to put on those shoes and walk out into the world.

After IVF, the couple decided to freeze their embryo for three years to allow Seth adequate time to re-start his testosterone and recover from an exhausting battle with their insurance company, which ultimately denied coverage (with the exception of Leahs pre-natal care).

Seth had requestedfertility preservation coverage, which, according to the National Institutes of Health (NIH),allows patients to save their eggs and sperm before undergoing treatment for medical conditions such as cancer. Seth argued that testosterone injections for hisgender dysphoria diagnosiscould ultimately impair his fertility, however, his insurance company denied coverage and appeals to the State Department of Health in Massachusetts (the state where Seths company was based) failed, as well.

Gender dysphoria, as defined by the American Psychiatric Association, involves a conflict between a person's physical or assigned gender and the gender with which he/she/they identify. People with gender dysphoria may be very uncomfortable with the gender they were assigned, sometimes described as being uncomfortable with their body (particularly developments during puberty) or being uncomfortable with the expected roles of their assigned gender.

The term was recently eliminated from the mental health category by theInternational Classification of Diseases (ICD)says Dana Bevin, Ph.D., a research psychologist in Georgia. Long before that, theDiagnostic and Statistical Manual of Mental Disorders (DSM)replaced the term gender identity disorder with gender dysphoria to help eradicate mental health stigmas.

The idea was to give gender dysphoria a medical diagnosis and de-pathologize the term, Bevin tells Yahoo Lifestyle, adding that fertility preservation should be a covered service, according to thethe World Professional Association for Transgender Health (WPATH), a global organization that sets standards of care for medical and mental-health treatments.

The Marlows always remained focused on their dream, with Seth recently telling Andrea Syrtash, the founder of the online magazinePregnantishandthe podcast of the same name, I kept going because I had a very clear guidance for myself, which we adopted mutually. For me, I knew that I could only do it one time and that was it...you hear people going through this all the time and theyll say its all worth it when you have a healthy baby. I knew that we might not get any baby and that I needed for it to be worth it to me regardless of what happened.

Seth added, And so I viewed it as an opportunity to maybe have a child with my wife and that opportunity had to be enough. We were really lucky. We have a beautiful child, but I couldnt set the goal.

The couple cashed out their retirement funds and went into debt to pay for the procedures, which totaled an estimated $30K, counting fertilization, freezing, two transfers, medication, storage fees, travel time and lost work wages.

Im so grateful to my wife, who has never made me feel that I had some sort of shortcoming, Seth tells Yahoo Lifestyle. She approached this like any other life challenge.

And Arlo, who was born in 2015, understands his birth story. He knows not every family is formed this way that whats true about one person or most people isnt true for everyone, Seth explains. I recently asked Arlo how he felt about a sibling and he asked, Will we use the same donor and egg?

Seth adds, We give him space to feel however he feels about it.

Related Video: Follow This Same-Sex Couples Incredible IVF Journey

Read more from Yahoo Lifestyle:

Read the original here:
Transgender dad used IVF to conceive his son: 'We were really lucky' - Yahoo Lifestyle


Nov 20

At-home testing kits could help Maryland residents engage in their health – WBAL TV Baltimore

As of October, Marylanders can now buy at-home test kits to check for things like diabetes, cholesterol and more.The state was one of four holdouts until the General Assembly passed a new law allowing it.Maryland residents don't have to head to the doctor for certain medical tests anymore. Now, residents can get tested for things like high cholesterol, diabetes and even testosterone from the comfort of home.Public health physician Dr. Charlene Brown said it's something to which everyone should have access."It reduces barriers to engaging in home health systems. I believe that at-home testing is the final frontier in terms of engaging people in their own health. People can answer their own questions and work closely with their physicians," Brown said. The sample you collect is sent off to the same labs that do the testing for doctors."The tests are accurate as any other tests being sent to the lab that's been inspected and cleared," Brown said. Brown said at-home test kits are good for busy people and people who are reluctant to call their doctor about a concern."I don't believe people should be off by themselves outside of the health system making decisions. It's a tool you can use in concert with your provider. Get the test, conduct the test then bring the results into your doctor," Brown said. Results will come in easy to understand, layman's language and a detailed report for your physician. It is important to check with your insurance company to see if the cost of the test is covered.In some instances, the at-home test may be cheaper than what your doctor orders or vice versa. Also, they can by bought in store or online.

As of October, Marylanders can now buy at-home test kits to check for things like diabetes, cholesterol and more.

The state was one of four holdouts until the General Assembly passed a new law allowing it.

Maryland residents don't have to head to the doctor for certain medical tests anymore. Now, residents can get tested for things like high cholesterol, diabetes and even testosterone from the comfort of home.

Public health physician Dr. Charlene Brown said it's something to which everyone should have access.

"It reduces barriers to engaging in home health systems. I believe that at-home testing is the final frontier in terms of engaging people in their own health. People can answer their own questions and work closely with their physicians," Brown said.

The sample you collect is sent off to the same labs that do the testing for doctors.

"The tests are accurate as any other tests being sent to the lab that's been inspected and cleared," Brown said.

Brown said at-home test kits are good for busy people and people who are reluctant to call their doctor about a concern.

"I don't believe people should be off by themselves outside of the health system making decisions. It's a tool you can use in concert with your provider. Get the test, conduct the test then bring the results into your doctor," Brown said.

Results will come in easy to understand, layman's language and a detailed report for your physician.

It is important to check with your insurance company to see if the cost of the test is covered.

In some instances, the at-home test may be cheaper than what your doctor orders or vice versa. Also, they can by bought in store or online.

Visit link:
At-home testing kits could help Maryland residents engage in their health - WBAL TV Baltimore


Nov 20

Why JinkoSolar Holding, America’s Car-Mart, and Myovant Sciences Jumped Today – The Motley Fool

The stock market once again found itself lacking clear direction, with different indexes moving in opposite directions. Most of the same big-picture issues remained on investors' minds, and weakness in the retail sector weighed on the generally upbeat sentiment that market participants have had about the health of the American consumer. A few stocks were able to post sizable gains despite some of those concerns. JinkoSolar Holding (NYSE:JKS), America's Car-Mart (NASDAQ:CRMT), and Myovant Sciences (NYSE:MYOV) were among the top performers. Here's why they did so well.

Shares of JinkoSolar rose more than 10% after the solar panel manufacturer announced its third-quarter financial results. Revenue climbed 12% from year-ago levels during the period, and module shipments increased 13% to 3,326 megawatts. Adjusted net income soared by nearly half from the year-earlier quarter. CEO Kangping Chen believes that the report "marks a turning point for our business," as production costs continued to fall even as shipments rose. Low oil prices haven't helped renewable energy stocks lately, but JinkoSolar is making smart moves and sees brighter skies ahead.

Image source: Getty Images.

America's Car-Mart saw its stock climb 10% following the company's release of fiscal second-quarter financials. Earnings jumped 23% from the year-ago period, and a 12.2% rise in same-store sales pointed to a healthy environment for the auto sales and finance specialist. America's Car-Mart sold almost 9% more vehicles than it did during last year's fiscal second quarter, and internal metrics like retail units sold per month and gross profit per unit sold showed modest gains. There's some uncertainty right now about the likely future course of the auto industry, but little in America's Car-Mart's report pointed to an imminent downturn for the company.

Finally, shares of Myovant Sciences skyrocketed 115%. The biotech company gave investors good news in the form of clinical results from its phase 3 HERO study of relugolix, its prostate cancer treatment candidate. Relugolix did extremely well, proving itself as an effective method of suppressing testosterone without creating undue adverse safety concerns. In response, Myovant now believes that it will seek approval for the drug from the U.S. Food and Drug Administration next year. Today's move shows just how high shareholders' hopes for relugolix are, but with advanced prostate cancer being a serious health problem, it's not surprising that a potentially game-changing drug would be valuable for the medical community and investors alike.

Continued here:
Why JinkoSolar Holding, America's Car-Mart, and Myovant Sciences Jumped Today - The Motley Fool


Nov 20

Training to be a powerlifter while trans can have real ramifications – ABC News

Posted November 20, 2019 07:07:55

It's nerve-wracking for any athlete to compete in their first competition, but for Beau Driscoll, the path to get there hasn't been easy.

Before he transitioned from female to male in 2016, team sports had been a big part of his life.

But when he began taking hormones, Mr Driscoll said he didn't feel there was space for him on any team.

Seven months ago he began powerlifting to lose weight he's lost 25 kilos and in January will participate in his first sanctioned powerlifting meet with GPC (Global Powerlifting Committee) Australia.

"It's a non-tested federation, so what that means is people can take performance-enhancing drugs and be able to compete because they don't do testing," Mr Driscoll said.

It's an important aspect for Mr Driscoll, as not every powerlifting federation is open to, or accepting of, trans powerlifters.

Mr Driscoll needs to take the hormone as part of his transition, but it is banned under tested powerlifting competitions because it's considered performance-enhancing, even for someone who is trans.

Although many powerlifting federations acknowledged athletes could be trans, many still didn't allow them to compete while taking hormones, the 28-year-old said.

"You can compete as the gender you identify as, but you can't be on hormones," he said.

"It's sort of invalidating in that sense, that 'yes, you can be who you want, we acknowledge that you're that, but you can't be on hormones'.

"Personally, I don't think it's fair."

He credits testosterone with helping him to feel more like himself.

"I'll get hair growth, my voice deepens and, as you can see, I look masculine.

"Before my transition, I didn't know who I was, it was a very uneasy ground for me, and then I started hormones in 2016 and I just feel so confident in who I am."

And he is adamant that it doesn't give him an advantage over his competitors.

"I have 1,000 milligrams of testosterone every seven weeks, and that puts my testosterone levels at the same as a cisgendered male who is not on any [performance-enhancing drugs].

"I'm at no advantage whatsoever."

Mr Driscoll has found support from people within his federation.

His friend, powerlifter Niki Hart, said she had seen him mature in the sport.

"I feel like a proud gym mum," she said.

"When I see his working sets, when I see what he puts on the internet, I'm very proud of him and what he's done. His dedication is incredible."

She too has noticed barriers facing people like Mr Driscoll.

"There's some little loopholes that mean some organisations can discriminate against trans people ... that needs to change involvement in sport is a human right."

Fellow powerlifter Jake Hawker said it was important for sport to foster equal opportunity.

"I'm all for competing against people who are trans who want to be powerlifters, I think it's a great idea it's all about giving everyone the opportunity to compete."

Topics:lgbt,sexuality,people,powerlifting,community-and-society,human-interest,sport,carrum-downs-3201,cranbourne-3977,somerville-3912

Originally posted here:
Training to be a powerlifter while trans can have real ramifications - ABC News


Nov 19

Testosterone Replacement Therapy Market Report 2019 : Global Analysis and Forecast by 2027 – Eastlake Times

The Testosterone Replacement Therapy Market report is a thorough analysis of the market that offers a detailed assessment of the market situation for the forecast period 2019-2027. The report systematically explains market trends, growth opportunities, challenges, drivers, and other factors impacting the Testosterone Replacement Therapy market. The key focus of the report assists business owners in understanding the market in terms of its segmentation, regional distribution, and influential trends. The report will provide readers a comprehensive analysis of the Testosterone Replacement Therapy market with a broad perspective into the global economy and competitive landscape. The report contains first-hand data of market trends, obtained through rigorous research that can transform the arc of your Business.

Download PDF Brochure at:https://www.worldwidemarketreports.com/sample/106789

The Testosterone Replacement Therapy report offers the plus points as well as weaknesses of the established market players. It analyses numerous features of the global Testosterone Replacement Therapy market such as demand, drivers, challenges, and options. The report appraises the influence of these aspects on each market region during the estimated time. It presents the value chain analysis together with vendor list and highlights the present market situation between consumer and supplier.

In order to give the users of this report a comprehensive view of the Testosterone Replacement Therapy market, we have included a competitive landscape and an analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The years considered to estimate the Insights of Testosterone Replacement Therapy Market are as follows:-

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year: 2019 to 2027

Key Highlights of Global Testosterone Replacement Therapy Market Report 2019:

Snaps From the Testosterone Replacement Therapy Report / TOC :

1 Market Overview

1.1 Testosterone Replacement Therapy Introduction

1.2 Market Analysis by Type

1.3 Market Analysis by Applications

1.4 Market Analysis by Regions

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America, Middle East and Africa

1.5 Market Dynamics

2 Manufacturers Profiles

3 Global Testosterone Replacement Therapy Market Competition, by Manufacturer

4 Global Testosterone Replacement Therapy Market Analysis by Regions

4.1 Global Testosterone Replacement Therapy Sales, Revenue and Market Share by Regions

(continued)

Ask for the Complete TOC or Any Quiry accepted at:https://www.worldwidemarketreports.com/quiry/106789

10 Global Testosterone Replacement Therapy Market Segment by Type

11 Global Testosterone Replacement Therapy Market Segment by Application

12 Testosterone Replacement Therapy Market Forecast (2019-2027)

13 Sales Channel, Distributors, Traders and Dealers

14 Research Findings and Conclusion

Testosterone Replacement Therapy market will prove as a valuable source of guidance for professional clients like Tier 1, Tier 2, Tier 3 level managers, CEOs, CMOs, as well as interested individual readers across the world. Vendor Landscape provide acts as key development and focus of above professional with common aim to lead the way of Testosterone Replacement Therapy market Worldwide.

If you have any special requirements, please let us know and we will offer you the report as you want.

Read more:
Testosterone Replacement Therapy Market Report 2019 : Global Analysis and Forecast by 2027 - Eastlake Times



Page 86«..1020..85868788..100..»


matomo tracker